Evidence map›Paper›PMID 27815195›Full record

ReviewBiochimica et biophysica acta. Gene regulatory mechanisms2017

NF-Y (CBF) regulation in specific cell types and mouse models.

Sankar N Maity

Abstract readReview
In one paragraph

Review in Biochimica et biophysica acta. Gene regulatory mechanisms, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Integrative single-cell RNA-seq and ATAC-seq identifies transcriptional and epigenetic blueprint guiding osteoclastogenic trajectory.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2025
    Article
  2. Article
  3. The role(s) of NF-Y in development and differentiation.Cell death and differentiation · 2025
    Review
  4. Article
  5. Genome-Wide Identification and Expression Analysis of theInternational journal of molecular sciences · 2024
    Article
  6. Article
  7. Myo-differentiation reporter screen reveals NF-Y as an activator of PAX3-FOXO1 in rhabdomyosarcoma.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  8. Article
  9. Review
  10. Article
  11. On the NF-Y regulome as in ENCODE (2019).PLoS computational biology · 2020
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Sankar N MaityDepartment of Genitourinary Medical Oncology, David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, TX, United States. Electronic address: smaity@mdanderson.org.

Funding

ROLE OF CBF/NF-Y IN TRANSCRIPTION: TYPE I COLLAGEN GENESR01AR046264 · NIAMS · UNIVERSITY OF TEXAS MD ANDERSON CAN CTR · PI MAITY, SANKAR N · 2000 to 2004
$1.3M
NIAMS NIH HHS R01 AR046264
6 · The paper itself

Abstract

The CCAAT-binding factor CBF/NF-Y is needed for cell proliferation and early embryonic development. NF-Y can regulate the expression of different cell type-specific genes that are activated by various physiological signaling pathways. Dysregulation of NF-Y was observed in pathogenic conditions in humans such as scleroderma, neurodegenerative disease, and cancer. Conditional inactivation of the NF-YA gene in mice demonstrated that NF-Y activity is essential for normal tissue homeostasis, survival, and metabolic function. Altogether, NF-Y is an essential transcription factor that plays a critical role in mammalian development, from the early stages to adulthood, and in human pathogenesis. This article is part of a Special Issue entitled: Nuclear Factor Y in Development and Disease, edited by Prof. Roberto Mantovani.

Indexed as

AnimalsCCAAT-Binding FactorHumansMiceNeoplasm ProteinsNeoplasms, ExperimentalNeurodegenerative DiseasesScleroderma, DiffuseCCAAT-Binding FactorNeoplasm ProteinsCCAAT binding factorCell type specificConditional inactivation in miceNF-YTissue homeostasis

Identifiers

PMID27815195
PMCPMC5413426

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.